Does Low-grade Follicular Lymphoma With a High Proliferation Index Require a Different Treatment Strategy? A Single Center Experience
Our data suggest that a different treatment approach may not be warranted for LG/HP FL patients.
Authors
- Urwat Til Vusqa (ORCID: https://orcid.org/0000-0001-7981-6528)
- Eshan Khan (ORCID: https://orcid.org/0000-0001-7415-5652)
- H. Abdulahi
- Yazan Samhouri (ORCID: https://orcid.org/0000-0003-0271-4798)
- Rahim Jiwani (ORCID: https://orcid.org/0000-0002-1324-865X)
- Cyrus Khan
Institutions
- Allegheny Health Network (US)
- Cooper University Hospital (US)
- Cooper Medical School of Rowan University (US)
- UPMC Hillman Cancer Center (US)
- Cooper University Health Care (US)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-12-30
- DOI
- https://doi.org/10.21873/anticanres.17408
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00